A study of the producers of spam e-mail messages has found that the biggest operators in the illicit sector are making considerable profits from the sale of counterfeit or imitation drugs, according to research carried out in the USA. Pat Peterson, the sponsor of the study, is an expert on anti-spam solutions and a fellow of the networking and communications technology and services giant, Cisco Systems. He has spent 18 months examining the e-mails sent via Storm, a type of computer virus that allows a person's computer to be secretly used to send mass e-mails. One on-line pharmacy identified in the study, which claims to be based in Canada, has an annual turnover of $150.0 million offering product which really originates in Mumbai, India, or Shanghai, China.
Among the study's findings is a shift from traditional fraud involving the offering of a service for the purpose of stealing a person's credit card details, to actually supplying a plausible imitation of the product. In the case of branded prescription medicines, such as the most commonly-touted erectile dysfunction drug, Pfizer's Viagra (sildenafil citrate), the more entrepreneurial spammers are offering fake tablets containing between 100% and 110% of the active ingredient.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze